Biogen to buy the retinal gene therapy maker Nightstar
Tuesday, May 28, 2019 - 21:11
in Mathematics & Economics
The $800 million purchase is the third gene therapy acquisition announced in a week
The $800 million purchase is the third gene therapy acquisition announced in a week